Study of the performance of Centum stent

Not Applicable

Recruiting

• Conditions: Diseases of the circulatory system

• Registration Number: KCT0007831
• Lead Sponsor: Wonkwang University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 November 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 816

Inclusion Criteria

Patients of acute coronary syndrome (unstable angina or myocardial infarction) who are over 19 years of age
Patients participating voluntarily in the study and who have signed the consent form
Patients who have undergone an interventional procedure using Centum stents in the last one month

Exclusion Criteria

Subjects with restrictions or hypersensitivity to the following drugs or materials: contrast agent, heparin, aspirin, clopidogrel, everolimus, etc. (Subjects with hypersensitivity to contrast agents may enroll in the study if such reaction can be controlled with steroid or pheniramine. Subjects with a history of anaphylaxis should be excluded.)
Subjects who are breast-feeding, pregnant or hoping to become pregnant
Subjects with life expectancy of less than 1 year
Subjects determined unfit by the investigator

Study & Design

• Study Type: Observational Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Target vessek failure

Secondary Outcome Measures

Name	Time	Method
Major adverse cardiac events